Based on the Goodrx Holdings Inc stock forecast from 10 analysts, the average analyst target price for Goodrx Holdings Inc is USD 8.97 over the next 12 months. Goodrx Holdings Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Goodrx Holdings Inc is Slightly Bearish, which is based on 6 positive signals and 8 negative signals. At the last closing, Goodrx Holdings Inc’s stock price was USD 4.44. Goodrx Holdings Inc’s stock price has changed by -5.73% over the past week, -9.39% over the past month and -30.84% over the last year.
No recent analyst target price found for Goodrx Holdings Inc
No recent average analyst rating found for Goodrx Holdings Inc
Company Overview Goodrx Holdings Inc
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscriptions, and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California. Read Less
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, g...Read More
Frequently Asked Questions About Goodrx Holdings Inc (GDRX) Stock
Based on ratings from 10 analysts Goodrx Holdings Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 9 buy, 1 sell and 5 hold ratings.
Unfortunately we do not have enough data on GDRX's stock to indicate if its a good dividend stock.
Based on targets from 10 analysts, the average taret price for GDRX is USD 8.97 over the next 12 months. The maximum analyst target price is USD 20 while the minimum anlayst target price is USD 5.
GDRX stock's Price/Earning ratio is 199.67.
Our analysis grades GDRX stock's Price / Earning ratio at F. This means that GDRX stock's Price/Earning ratio is above 78% of the stocks in the Health Information Services sector in the NSD exchange.
Based on this GDRX may be a overvalued for its sector.
The last closing price of GDRX's stock was USD 4.44.
The most recent market capitalization for GDRX is USD 1.87B.
Based on targets from 10 analysts, the average taret price for GDRX is projected at USD 8.97 over the next 12 months.
This means that GDRX's stock price may go up by +101.95% over the next 12 months.
We can't find any ETFs which contains Goodrx Holdings Inc's stock.
As per our most recent records Goodrx Holdings Inc has 694 Employees.
Goodrx Holdings Inc's registered address is 2701 Olympic Boulevard, Santa Monica, CA, United States, 90404.
You can get more information about it from Goodrx Holdings Inc's website at https://www.goodrx.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Goodrx Holdings Inc (GDRX) Stock
Based on ratings from 10 analysts Goodrx Holdings Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 9 buy, 1 sell and 5 hold ratings.
Unfortunately we do not have enough data on GDRX's stock to indicate if its a good dividend stock.
Based on targets from 10 analysts, the average taret price for GDRX is USD 8.97 over the next 12 months. The maximum analyst target price is USD 20 while the minimum anlayst target price is USD 5.
GDRX stock's Price/Earning ratio is 199.67.
Our analysis grades GDRX stock's Price / Earning ratio at F. This means that GDRX stock's Price/Earning ratio is above 78% of the stocks in the Health Information Services sector in the NSD exchange.
Based on this GDRX may be a overvalued for its sector.
The last closing price of GDRX's stock was USD 4.44.
The most recent market capitalization for GDRX is USD 1.87B.
Based on targets from 10 analysts, the average taret price for GDRX is projected at USD 8.97 over the next 12 months.
This means that GDRX's stock price may go up by +101.95% over the next 12 months.
We can't find any ETFs which contains Goodrx Holdings Inc's stock.
As per our most recent records Goodrx Holdings Inc has 694 Employees.
Goodrx Holdings Inc's registered address is 2701 Olympic Boulevard, Santa Monica, CA, United States, 90404.
You can get more information about it from Goodrx Holdings Inc's website at https://www.goodrx.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for GDRX !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
